VP, Head of Clinical BioAnalytics & Translational Sciences
Beam Therapeutics
Cambridge, Massachusetts, United States
I have a PhD in Biochemistry with four years of academic and twenty plus years of pharmaceutical drug discovery & development experience from target id through development, submission, approval, launch & post-marketing.
I’ve had leadership roles of increasing responsibility managing functional organizations, matrix teams and development programs while specializing in Translational Sciences, Translational Medicine, Clinical BioAnalytics, Biomarker & Diagnostic strategy, discovery, development & Implementation for Immunology, Immuno-Oncology, Inflammation, GI/Metabolic, Fibrosis, Hematology, Neuromuscular, and Rare Genetic diseases at Wyeth, Pfizer, Takeda (L-Shire) and Biogen.
I am currently Vice President and Head of Clinical Bioanalytics & Translational Sciences at Beam Therapeutics managing a function that works across R&D and holds responsibility for bioanalytical, forward & reverse translational strategies followed by implementation for a broad pipeline of clinical programs in hematology, immunology, oncology, and rare genetic diseases that leverage base editing technologies, auto/allo cell therapies and novel delivery modalities like LNP.
Disclosure information not submitted.
Monday, April 24, 2023
1:00 PM – 2:00 PM ET